drugset / Trial / NCT00305929
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multi-centre, phase II, open-label, 12-month clinical trial for patients previously treated with WST09 (Tookad) who have positive prostate biopsies for cancer. The study aims at delivering a second WST09 treatment for the purpose of eradicating the localized prostate cancer.
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TOOKAD | Other / unclassified | 2 mg/kg | Intravenous |